Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type - Weinstein, Cindy; Jordan, Karin; Green, Stuart; Khanani, Saleem; Beckford-Brathwaite, Elizabeth; Vallejos, Waldimir; Pong, Annpey; Noga, Stephen J.; Rapoport, Bernardo L. (BMC cancer, 2020)
Gesehen am 04.12.2020